Recombinant Human Angiotensin-converting enzyme 2 (ACE2) Extracellular Domain |
Recombinant Protein, SARS-CoV-2 |
|
|
ACE-2 protein, Angiotensin-I-converting enzyme |
Detail |
Recombinant Human Interleukin-2 (IL-2)-BSA |
Recombinant Protein, Cytokine |
|
|
|
Detail |
Recombinant Human Interleukin-2 (IL-2)-CF |
Recombinant Protein, Cytokine |
|
|
|
Detail |
Recombinant Human Interleukin-6 (IL-6)-BSA |
Recombinant Protein, Cytokine |
|
|
|
Detail |
Recombinant Human Interleukin-6 (IL-6)-CF |
Recombinant Protein, Cytokine |
|
|
|
Detail |
Recombinant Human SARS-CoV-2 Nucleoprotein (E. Coli) |
Recombinant Protein, SARS-CoV-2 |
|
|
SARS-CoV nucleoprotein, Nucleocapsid protein, N protein |
Detail |
Recombinant Human SARS-CoV-2 Nucleoprotein (HEK) |
Recombinant Protein, SARS-CoV-2 |
|
|
SARS-CoV nucleoprotein, Nucleocapsid protein, N protein |
Detail |
Recombinant Human SARS-CoV-2 Spike Glycoprotein S1 RBD (CHO) |
Recombinant Protein, SARS-CoV-2 |
|
|
SARS-CoV S, RBD, S protein, Glycoprotein S1 |
Detail |
Recombinant Human SARS-CoV-2 Spike Glycoprotein S1 RBD (HEK) |
Recombinant Protein, SARS-CoV-2 |
|
|
SARS-CoV S, RBD, S protein, Glycoprotein S1 |
Detail |
Recombinant Human SARS-CoV-2 Spike RBD Variant B.1.1.248 (HEK) |
Recombinant Protein, SARS-CoV-2 |
|
|
SARS-CoV S, RBD, S protein, Glycoprotein S1, Variant Lineage B.1.1.248 (Brazil & Japan) |
Detail |
Recombinant Human SARS-CoV-2 Spike RBD Variant N501Y, Lineage B.1.1.7 (HEK) |
Recombinant Protein, SARS-CoV-2 |
|
|
SARS-CoV S, RBD, S protein, Glycoprotein S1, VOC-202012/01 (United Kingdom) |
Detail |
Recombinant Human SARS-CoV-2 Spike RBD Variant N501Y.V2, Lineage B.1.351 (HEK) |
Recombinant Protein, SARS-CoV-2 |
|
|
SARS-CoV S, RBD, S protein, Glycoprotein S1, 20C/501Y.V2 (South Africa) |
Detail |